Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-04

Clinical Trial Update: Clinical Trial in Children Between 3 Months and 14 Years Old to Evaluate the Efficacy and Safety of Gelatin Tannate in the Treatment of Acute Diarrhea (INDIGO) [Phase 3]

View source ↗

Summary

Phase 3 trial in children aged 3 months to 14 years evaluating gelatin tannate for acute diarrhea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gelatin tannate (gelatin tannate)

Snippet

Sponsor: Ferrer Internacional S.A. | Conditions: Diarrhea | Phase 3 | Status: COMPLETED